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Abstract We present six cases of extra-axial lesions:
three meningiomas [including one intraventricular and one
cerebellopontine angle (CPA) meningioma], one dural
metastasis, one CPA schwannoma and one choroid plexus
papilloma which were chosen from a larger cohort of extra-
axial tumors evaluated in our institution. Apart from con-
ventional MR examinations, all the patients also underwent
perfusion-weighted imaging (PWI) using dynamic suscep-
tibility contrast method on a 1.5 T MR unit (contrast:
0.3 mmol/kg, rate 5 ml/s). Though the presented tumors
showed very similar appearance on conventional MR ima-
ges, they differed signiﬁcantly in perfusion examinations.
The article draws special attention to the usefulness of PWI
in the differentiation of various extra-axial tumors and its
contribution in reaching ﬁnal correct diagnoses. Finding a
dural lesion with low perfusion parameters strongly argues
against the diagnosis of meningioma and should raise a
suspicion of a dural metastasis. In cases of CPA tumors, a
lesion with low relative cerebral blood volume values
should be suspected to be schwannoma, allowing exclusion
of meningioma to be made. In intraventricular tumors
arising from choroid plexus, low perfusion parameters can
exclude a diagnosis of meningioma. In our opinion, PWI as
an easy and quick to perform functional technique should be
incorporated into the MR protocol of all intracranial tumors
including extra-axial neoplasms.
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Introduction
Intracranial extra-axial neoplasms are tumors arising from
tissues other than brain parenchyma, such as meninges,
dura, calvarium, ventricles, choroid plexus, pineal gland or
pituitary gland, with meningiomas being the most common
type comprising 13–26% of all intracranial neoplasms in
adults [1]. Meningiomas originate from arachnoid men-
ingothelial cells and appear as broad-based dural hemi-
spheric or oval lesions, attached to the dura mater. They
most frequently occur supratentorially at calvaria or skull
base meninges, along falx and in the parafalcine location,
but they can also be found attached to tentorium, in the
cerebellopontine angle (CPA), within the optic nerve or
intraventricularly. Though they have a fairly characteristic
appearance on CT and MRI, they need to be differentiated
from other extra-axial lesions that can strongly mimic
meningiomas both clinically and radiologically, such as
metastases, primary glial and mesenchymal tumors, he-
matopoetic neoplasms (lymphomas, plasmocytomas) or
even inﬂammatory (reumathoid arthritis) and infectious
diseases (tuberculosis) [2]. If located in the CPA, menin-
giomas can be difﬁcult to distinguish from vestibular sch-
wannomas, and if located within ventricles, they need to be
differentiated from other ventricle tumors such as choroid
plexus papillomas or ependymomas.
As many extra-axial lesions are indistinguishable from
meningiomas using conventional MRI, the advanced MR
techniques such as MR spectroscopy (MRS) and perfusion-
weighted imaging (PWI) can be applied to obtain more
informationontumorbiology.MRShasbeenwidelyusedin
glial tumors but its application in extra-axial tumors is still
limited. MRS is capable of the differentiation of various
extra-axial tumors on the basis of metabolite spectra (high
alanine and low N-acetylaspartate peaks in meningiomas,
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lipidpeaksinmetastases)[3].Ontheotherhand,MRScanbe
difﬁculttoperforminextra-axialtumorsduetotheirlocation
near the skull and bone artefacts especially in the CPA, thus
making this technique limited mainly to large lesions [4].
PWI is a method that provides information on cerebral
physiologyatthecapillarylevel(microvasculature).Among
a few PWI techniques, dynamic susceptibility contrast
(DSC) MR imaging is the most often used. The method is
based on the measurements of the MR signal using T2*-
weighted sequence during the ﬁrst pass of a bolus of a
paramagneticcontrastagent[5].DSCMRIprovidesmapsof
cerebral blood volume (CBV) and noninvasive measure-
ments of relative cerebral blood volume (rCBV). In brain
tumors, rCBV is deﬁned as the ratio between CBV in the
tumor and CBV in the white matter of the contralateral
hemisphere. rCBV parameter correlates with tumor vascu-
larityandisincreasedintumorswithahighrateofpathologic
neoangiogenesis [6]. In glial tumors, increased rCBV ratios
indicate increased malignancy, but this rule cannot be
applied to extra-axial tumors—there are highly vascular
extra-axial tumors, e.g., meningiomas, which are benign in
terms of biological behavior [7].
Since most of the PWI studies of intracranial tumors
have focused on glial neoplasms, this article draws special
attention to the usefulness of PWI in differentiation of
various extra-axial tumors and its contribution in reaching
a ﬁnal correct diagnosis. We present six cases of extra-
axial tumors which show very similar appearance on con-
ventional MR images and differ signiﬁcantly in perfusion
examination.
Materials and methods
We present six cases of extra-axial lesions: three menin-
giomas (including one intraventricular and one CPA
meningioma), one dural metastasis, one CPA schwannoma
and one choroid plexus papilloma. All patients underwent
conventional MR imaging followed by DSC MRI. The
cases were selected from a cohort of 32 extra-axial tumors
evaluated with PWI in our institution in the years
2008–2009. The histopathological diagnosis was estab-
lished in all patients by a neuropathologist according to the
World Health Organization classiﬁcation system for tumors
of the central nervous system.
Data acquisition
The imaging examinations were performed with 1.5 T MR
unit (Signa Hdx; GE Medical Systems) using a 16-channel
coil dedicated for head and spine imaging. Before con-
trast injection, standard brain protocol was applied:
non-enhanced axial T1-weighted images, axial, coronal
and sagittal T2-weighted images and axial ﬂuid attenuated
inversion recovery sequences were obtained. Then, DSC
MR imaging was performed using gradient echo planar
T2*-weighted sequence with the following parameters:
TR = 1.900 ms, TE = 80 ms, FOV = 30 cm, matrix =
192 9 128, slice thickness = 8 mm without spacing, NEX
1.0. Ten seconds after the start of the image acquisition, a
bolus of a 1.0-mmol/l gadobutrol formula (Gadovist;
Schering Bayer Pharma) in a dose of 0.3 mmol/kg of body
weight (as indicated by the producing company) was
injected via 20-gauge catheter placed in the antecubital
vein. Contrast administration was performed using an
automatic injector (Medrad) at a rate of 5 ml/s and was
followed by a saline bolus (20 ml at 5 ml/s). The whole
perfusion imaging lasted 1 min 26 s, in which sets of
images from 13 axial slices parallel to the anterior com-
misure–posterior commisure plane were obtained before,
during and after contrast injection. After dynamic studies,
postcontrast T1-weighted 3D images were performed using
contrast administered for perfusion examination.
Image postprocessing
The dynamic images were postprocessed using Functool
software (ADW 4.4; GE Medical Systems). CBV maps
were computed on a pixel-wise basis from the ﬁrst–pass
data as described by Rosen et al. [5]. CBV values obtained
with this methodology are not absolute measurements and
require to be related to the reference standard. All CBV
values obtained within the tumor core were normalized to
the CBV values from the normal-appearing contralateral
white matter. In each tumor, color-coded perfusion maps as
well as rCBV values and time-intensity curves were
analyzed.
Results
Case 1 (Fig. 1a–c)
A 50-year-old male. MR images demonstrated a dural
tumor located along falx with broad attachment to
meninges. The lesion was hypointense on T1- and hyper-
intense on T2-weighted images with mild surrounding
edema. After contrast injection, the tumor enhanced
strongly, mostly homogeneously, with central necrosis;
peritumoral dural enhancement (dural tail sign) was also
visible. Moderate mass effect was present. Perfusion maps
showed marked hyperperfusion (rCBV = 18.7), and the
time-intensity curve revealed strong signal drop with no
return to the baseline. Histopathologically angiomatous
meningioma was diagnosed.
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123Case 2 (Fig. 1d–f)
A 58-year-old male. MR images demonstrated a meningi-
oma-like dural tumor located along tentorium on the right
side in the posterior cranial fossa. The lesion showed signal
intensity similar to cerebellar parenchyma on T1-weighted
images, while on T2-weighted images the tumor was hypo-
intense. Mild peritumoral edema was also seen. After con-
trastinjection,heterogeneousenhancementandtheduraltail
sign were noticed. No other enhancing pathological lesions
were found within the brain. Perfusion maps showed very
low rCBV values (rCBV = 0.4) with the time-intensity
curve returning to the baseline. The patient did not have any
history of a neoplastic disease. Gross pathology revealed
duralmetastasisofthesquamouscellcarcinomaofthelungs.
Case 3 (Fig. 2a–c)
A 54-year-old male. MR images showed a CPA tumor
arising from the right internal auditory canal (IAC) which
was moderately enlarged. The tumor was hypointense on
T1- and hyperintense on T2-weighted images and showed
strong homogeneous enhancement after contrast adminis-
tration. Moderate mass effect was noticed. rCBV map
showed hypoperfusion (rCBV = 0.5) and the time-inten-
sity curve returned to the baseline. Histopathological
evaluation revealed schwannoma.
Case 4 (Fig. 2d–f)
A 51-year-old male. MR images demonstrated a CPA
tumor with attachment to meninges and an intracanalicular
part detected after contrast administration. The lesion was
isointense on T1- and hypointense on T2-weighted images
and showed strong homogeneous enhancement after con-
trast injection. Perfusion maps revealed high rCBV values
(rCBV = 7.0), and the time-intensity curve a pronounced
signal drop with no return to the baseline. Histopathology
revealed ﬁbrous meningioma.
Case 5 (Fig. 3a–c)
A 23-year-old male. MR images demonstrated intraven-
tricular tumor located in the body of the left lateral
Fig. 1 Two dural lesions: T1 post-contrast (a, d) images, CBV maps
(b, e) and time-intensity curves (c, f). a–c Parafalcine meningioma
with high rCBV values (red coloring) on perfusion maps and the
typical time-intensity curve with no return to the baseline after high
signal drop (violet curve). d–f Dural metastasis mimicking meningi-
oma on conventional MR images but with low rCBV values (blue
coloring) and the time-intensity curve returning to the baseline (violet
curve)
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123ventricle. On T1- and T2-weighted images, the lesion was
isointense to the cortex and enhanced strongly, but slightly
heterogeneously, after contrast administration. Mild ven-
tricle enlargement was seen. Perfusion maps showed
hypoperfusion in the center (rCBV = 0.65) with moder-
ately elevated rCBV values (up to 1.8) peripherally. Per-
fusion time-intensity curve did not return to the baseline.
Histopathological evaluation revealed a choroid plexus
papilloma.
Case 6 (Fig. 3d–f)
A 23-year-old female. MR images showed intraventricular
tumor located in the trigone of the left lateral ventricle. On
T1- and T2-weighted images, the lesion was isointense to
the cortex and enhanced strongly and homogeneously after
contrast injection. Perfusion maps showed pronounced
hyperperfusion (rCBV = 10.4) and the time-intensity
curve demonstrated no return to the baseline after strong
signal drop. Histopathology revealed intraventricular
meningioma.
Discussion
Meningiomas are the most common primary nonglial
neoplasms with typical radiological features. On CT, they
usually appear as hyperdense, often calciﬁed lesions; on
MRI, they are mostly isointense with cortex on all
sequences. Meningiomas enhance strongly after contrast
injection and often homogeneously, but areas of necrosis
especially in large lesions can also be seen. Though not
speciﬁc for meningiomas, they very often produce the so-
called dural tail sign which is enhancing thickened perit-
umoral dura [8].
Meningiomas are highly vascular tumors, and in PWI,
they appear as hyperperfused lesions with elevated rCBV
values. InseveralDSCexaminations,meanrCBV valuesfor
all meningiomas were reported to range between 6 and 9 [9,
10] and were lower for meningothelial, ﬁbrous and ana-
plastic meningiomas (mean rCBV = 5–7) and higher for
angiomatousmeningiomas(meanrCBV = 11.9)[11].Also,
in all our cases of meningiomas, high perfusion results were
demonstrated (rCBV = 7.05 for CPA meningioma,
rCBV = 10.4 for intraventricular meningioma) with the
Fig. 2 Two CPA tumors: T1 post-contrast (a, d) images, CBV maps
(b, e) and time-intensity curves (c, f). a–c Typical schwannoma with
low perfusion parameters (blue coloring) and the time-intensity curve
returning to the baseline (violet curve). d–f Meningioma with
intracanalicular enhancing part showing typical hyperperfusion (red
coloring) and the time-intensity curve with no return to the baseline
(violet curve)
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gioma (rCBV = 18.7).
Apart from characteristic rCBV values, meningiomas
usually show typical time-intensity curves with minimal or
no return to the baseline level [12]. This phenomenon is
due to the absence of the blood–brain barrier in neovessels
of these tumors and thus the high rate of extracapillary
leakage of contrast material. The typical time-intensity
curves were seen in all our cases of meningiomas regard-
less of their location within falx, in the CPA or intraven-
tricularly (Figs. 1c, 2f and 3f).
Though meningiomas are the most common dural
tumors, they need to be differentiated with other meningeal
lesions, in particular meningeal metastases, from prostate,
lung, kidney or breast cancers [13]. If lesions arise multi-
focally within meninges, they are highly suggestive of
metastases, but if they present as a solitary tumor especially
in a patient without previous history of primary malignancy
like in our case 2, they can cause severe diagnostic prob-
lems. Isolated dural metastases representing less than 1% of
intracranial metastases [14] strongly mimic meningiomas,
and less than 40 cases of dural metastases interpreted as
meningiomas have been previously reported [2, 4, 13, 15].
Kremer et al., evaluating 6 dural metastases and 16
meningiomas, did not ﬁnd any signiﬁcant differences
between those lesions on conventional MR images [10].
Both dural metastases and meningiomas showed similar
appearance on T1- and T2-weighted images, similar hetero-
or homogeneous contrast enhancement pattern, and a dural
tail sign. Also, in our cases 1 and 2, plain MR images were
not sufﬁcient to discriminate both lesions. Though the two
lesions looked very similar on conventional MR images, we
noticed signiﬁcant differences between them in PWI—a
meningioma showed typical very high (18.7) and a metas-
tasis low (0.4) CBV ratios. Our ﬁndings are consistent with
the previous reports from perfusion studies of meningiomas
and dural metastases. Kremer et al. found that the mean
rCBV values of 16 meningiomas (mean rCBV = 8.97,
range 4–18) were signiﬁcantly higher than those of dural
metastases of a lung carcinoma (one case: 1.26), lymphoma
(one case: 1.29), breast carcinoma (two cases: 1.5, 1.56) and
rectal carcinoma (one case: 3.34) [10]. It also has to be
Fig. 3 Two intraventricular tumors: T1 post-contrast (a, d) images,
CBV maps (b, e) and time-intensity curves (c, f). a–c choroid plexus
papilloma with low rCBV values on perfusion maps (blue and green
coloring) and the time-intensity curves showing no return to the
baseline (violet curves). d–f intraventricular meningioma with typical
high rCBV values (red coloring) and the time-intensity curve with no
return to the baseline (violet curve)
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perfusion results, but not all of them. Hypervascular lesions
such as Merkel carcinoma, kidney carcinoma or melanoma
metastases may present elevated rCBV values which make
them indistinguishable from meningiomas [10, 16].
High-grade astrocytomas invading the dura mater may
also be difﬁcult to distinguish from meningiomas on plain
MRI. Moreover, both lesions show high rCBV values in
PWI [6, 9]. Cha et al. suggest that in those cases evaluation
of the time-intensity curve during the ﬁrst pass is of special
importance and can be helpful in differentiating between
these two tumor types. In extra-axial tumors, the curve
does not return to baseline, which was also seen in all our
cases of meningiomas (Figs. 1c, 2f and 3f), whereas in
high-grade gliomas, there is a signiﬁcant partial return of
the curve to the baseline levels [12]. Other dural lesions
mimicking meningiomas such as infectious or inﬂamma-
tory diseases are rare and will not be discussed [2].
Meningiomas located in the CPA account for 10–15% of
all lesions in this location and should in particular be dif-
ferentiated from vestibular schwannomas accounting for
70–80% of all CPA lesions [17, 18]. Other CPA lesions are
rare, with the epidermoid cyst being the most frequent
(5%) [17]. Most vestibular schwannomas develop from the
Schwann cells in the sheath of the inferior vestibular nerve
in the IAC. When they grow bigger and give rise to a round
or oval component in the CPA cistern, schwannomas can
be typically seen as ‘‘ice on cone’’ lesions. On MR images,
they show T1-isointensity and T2 high signal intensity,
homo- or heterogeneous enhancement and may contain
cystic or necrotic components, especially in lesions
exceeding 2.5 cm [19]. The differential diagnostic prob-
lems can be caused by larger schwannomas without an
obvious intracanalicular part and with a dural tail (sug-
gestive of meningioma) or by meningiomas with dural
enhancement within IAC (suggestive of schwannoma) like
in our case 4. Because MR image is not always conclusive,
PWI may be helpful to solve difﬁcult cases. The rCBV
values evaluated with DSC MRI are reported to be sig-
niﬁcantly lower in schwannomas than in meningiomas [9,
20], with the mean rCBV values 3.23 and 8.02, respec-
tively. Even if there is an overlap between rCBV ratios of
both entities, the highest reported ratios in schwannomas
did not exceed 4.4 while the mean rCBV ratio of typical
meningiomas ranges from 6 to 9 [7, 9, 10]. In our cases 3
and 4, perfusion results were similar to those reported in
the literature. Though both tumors enhanced strongly after
contrast administration, they showed different perfusion
results—low rCBV values in schwannoma (Fig. 2b) and
high rCBV values in meningioma (Fig. 2e). It is important
to remember that the pattern of perfusion within the tumor
does not reproduce enhancement characteristics found in
the post-contrast MRI, since in conventional MRI contrast
enhancement represents areas of disrupted blood–brain
barrier rather than tumor vascularity per se [21, 22]. Areas
of hyperperfusion in PWI can be identiﬁed in both
enhancing and nonenhancing tumor regions, and con-
versely strongly enhancing tumors may show both high or
low perfusion results in PWI. This is the case in schwan-
nomas and meningiomas which both strongly enhance in
conventional post-contrast MRI studies due to the lack of
the blood–brain barrier and signiﬁcant permeability of
tumor vessels for the contrast agent. Their different per-
fusion pattern reﬂects the rate of tumor vascularity which is
low in schwannomas and high in meningiomas [20].
Our cases 5 and 6 raise a problem of differentiation of
intraventricular lesions. Intraventricular tumors represent a
diverse group of lesions, some of them infrequent. The
most useful indication for the diagnosis are patients’ age
and precise intraventricular location. The most common
tumors arising from the choroid plexus are choroid plexus
papillomas, choroid plexus carcinomas, meningiomas and
metastases [23].
Choroid plexus papillomas account for 0.4–0.6% of all
intracranial tumors and nearly half of these tumors mani-
fest in the ﬁrst decade of life [24]. They usually arise in the
lateral or the forth ventricle. Choroid plexus papillomas are
cauliﬂower-like masses with prominent lobulations
peripherally, calciﬁcations, hemorrhage and cyst formation
seen occasionally. They appear as iso- or hyperdense
masses on CT and iso- or hypointense structures on T1-
weighted and heterogeneous on T2-weighted images. They
show strong enhancement on both CT and MR images.
Hydrocephalus is very common due to an increase in the
CSF production by the tumor [23, 24]. There are no reports
in the literature on the results of spectroscopic or perfusion
examinations in those tumors. Our study demonstrates low
values of rCBV in choroid plexus papilloma (Fig. 3b).
Intraventricular meningioma is a rare tumor, constitut-
ing approximately 0.5–2.0% of all intracranial meningio-
mas, but this tumor is still one of the most common
intraventricular neoplasms in the adult population [24, 25].
The majority of them occur after the fourth decade of life
though they might be present earlier like in our case 6.
Intraventricular meningiomas mostly occupy trigone of the
lateral ventricle and are believed to arise from the arach-
noidal cap cells trapped within the choroid plexus [24].
Their appearance on conventional imaging studies is sim-
ilar to that of other meningiomas [24, 25]. MRS of intra-
ventricular meningiomas has also revealed a pattern similar
to that of meningiomas outside the ventricular system with
decreased amounts of NAA, and increased amounts of
lactate, lipids and alanine [25]. To our knowledge, there are
no reports on the perfusion appearance of intraventricular
meningiomas. Our study proves that the perfusion results in
intraventricular meningiomas resemble those of other
782 J Neurooncol (2011) 103:777–783
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curve showing no return to the baseline (Fig. 3e, f).
Cases 5 and 6 show that choroid plexus papilloma and
intraventricular meningioma, though appearing similar on
conventional MR images, demonstrate different patterns of
perfusion: low rCBV values and high rCBV values,
respectively. We believe that DSC MRI can be helpful in
distinguishing those intraventricular lesions, though further
investigations including more cases are required to ﬁnd the
common perfusion patterns especially in choroid plexus
papillomas.
Conclusions
Optimal management of extra-axial lesions requires an
accurate preoperative diagnosis and PWI can provide
additional information helpful in distinguishing dural
metastases from meningiomas, CPA meningiomas from
schwannomas or intraventricular meningiomas from cho-
roid plexus papillomas.
Finding a dural lesion with low perfusion parameters
strongly argues against diagnosis of a meningioma and
should raise a suspicion of a dural metastasis. In cases of
CPA tumors, a lesion with low rCBV values should be
suspected to be schwannoma, allowing the exclusion of a
meningioma to be made. In intraventricular tumors arising
from choroid plexus, low perfusion parameters can exclude
a diagnosis of a meningioma.
In our opinion, PWI as an easy and quick to perform
functional technique should be incorporated into the MR
protocol of all intracranial tumors including extra-axial
neoplasms.
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